BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9455717)

  • 1. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between midazolam and clarithromycin: comparison with azithromycin.
    Yeates RA; Laufen H; Zimmermann T
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):400-5. PubMed ID: 8880291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
    Ito K; Ogihara K; Kanamitsu S; Itoh T
    Drug Metab Dispos; 2003 Jul; 31(7):945-54. PubMed ID: 12814973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
    Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
    Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin does not increase plasma concentrations of oral midazolam.
    Backman JT; Olkkola KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):356-9. PubMed ID: 7582388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Azithromycin: critical points].
    Philippon A; Cluzel R; Soussy CJ
    Pathol Biol (Paris); 1995 Jun; 43(6):488-97. PubMed ID: 8539070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide-induced digoxin toxicity: a population-based study.
    Gomes T; Mamdani MM; Juurlink DN
    Clin Pharmacol Ther; 2009 Oct; 86(4):383-6. PubMed ID: 19606089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of macrolide antibiotics on uptake of digoxin into rat liver.
    Ito S; Nasu R; Tsujimoto M; Murakami H; Ohtani H; Sawada Y
    Biopharm Drug Dispos; 2007 Apr; 28(3):113-23. PubMed ID: 17253595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of macrolide antibiotics.
    Ianaro A; Ialenti A; Maffia P; Sautebin L; Rombolà L; Carnuccio R; Iuvone T; D'Acquisto F; Di Rosa M
    J Pharmacol Exp Ther; 2000 Jan; 292(1):156-63. PubMed ID: 10604943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
    Suarez-Mier G; Giguère S; Lee EA
    J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The newer macrolides. Azithromycin and clarithromycin.
    Zuckerman JM; Kaye KM
    Infect Dis Clin North Am; 1995 Sep; 9(3):731-45. PubMed ID: 7490441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of azithromycin and clarithromycin in their interactions with rifabutin in healthy volunteers.
    Apseloff G; Foulds G; LaBoy-Goral L; Willavize S; Vincent J
    J Clin Pharmacol; 1998 Sep; 38(9):830-5. PubMed ID: 9753212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.